- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.05. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 07.05. | Inspira Technologies: INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients | 1 | GlobeNewswire (USA) | ||
| INSPIRA TECHNOLOGIES OXY BHN Aktie jetzt für 0€ handeln | |||||
| 23.04. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 15.04. | Inspira Technologies meldet erste Einnahmen aus FDA-zugelassenem Lebenserhaltungssystem | 2 | Investing.com Deutsch | ||
| 15.04. | Inspira Technologies reports initial revenue from FDA-cleared life support system | 4 | Investing.com | ||
| 15.04. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 15.04. | Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems | 154 | GlobeNewswire (Europe) | RA'ANANA, Israel, April 15, 2025 (GLOBE NEWSWIRE) -- RA'ANANA, Israel, April 15, 2025 -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support... ► Artikel lesen | |
| 07.04. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 25.03. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 14.03. | Inspira Technologies details strategic progress in respiratory care | 1 | Investing.com | ||
| 14.03. | Inspira Technologies informiert über strategische Fortschritte in der Atemwegsversorgung | 1 | Investing.com Deutsch | ||
| 13.03. | Inspira Technologies droht Delisting von der NASDAQ wegen Aktienkurs | 2 | Investing.com Deutsch | ||
| 13.03. | Inspira Technologies receives Nasdaq notification regarding minimum bid requirement | 3 | Seeking Alpha | ||
| 11.03. | Inspira Technologies Oxy B.H.N. reports FY results | 1 | Seeking Alpha | ||
| 11.03. | Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates | 107 | PR Newswire | Significant progress in HYLA blood sensor and INSPIRA ART core technologies
RA'ANANA, Israel, March 11, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N.... ► Artikel lesen | |
| 11.03. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.03. | Inspira Technologies OXY B.H.N. Ltd - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 05.03. | Inspira Technologies OXY B.H.N. Ltd - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 04.03. | Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy | 112 | PR Newswire | Inspira's AI-powered continuous blood monitoring technology demonstrated a high degree of accuracy in a key parameter, targeting multiple multi-billion-dollar market... ► Artikel lesen | |
| 04.03. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings |
Seite:
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,129 | -5,15 % | Sernova Biotherapeutics Inc: Sernova talks interim data from Cell Pouch trial | ||
| ATOSSA THERAPEUTICS | 0,905 | +16,32 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Full Results from I-SPY 2 Endocrine-Optimization Sub-Study Evaluating Low-Dose (Z)-Endoxifen | Feasibility endpoint achieved; rapid Ki-67 suppression and substantial MRI-confirmed tumor shrinkage observed with favorable safety profile
SEATTLE, May 14, 2025 /PRNewswire/ -- Atossa Therapeutics... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,802 | 0,00 % | Ping An Healthcare and Technology Company Limited: Ping An Health Reports 25.8% Year-on-Year Revenue Growth in Q1 2025, with Profitability Accelerating | Revenue and Profit Surge, Driven by "AI + Health Care" Value Empowerment
SHANGHAI and HONG KONG, April 24, 2025 /PRNewswire/ -- Ping An Healthcare and Technology... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,015 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,244 | -21,29 % | Co-Diagnostics GAAP EPS of -$0.24 beats by $0.03, revenue of $0.05M misses by $0.14M | ||
| CYTOSORBENTS | 0,697 | -6,82 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update | PRINCETON, N.J., May 14, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | 0,450 | -0,49 % | JTC Team, LLC: JTC Team Hosts Virtual Investor "KOL Connect" Segment to Discuss Veru Inc.'s Enobosarm Taking GLP-1 Weight Loss to Next Level | Moderated discussion with preeminent obesity expert Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder of Veru Watch the "KOL Connect" segment here FRENCHTOWN... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 7,050 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,465 | -2,52 % | VolitionRX Q1 2025 Earnings Preview | ||
| EKSO BIONICS | 0,388 | -3,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Accepted into NVIDIA Connect Program | ||
| IMUNON | 0,540 | -1,82 % | Imunon, Inc.: IMUNON Announces Six-Month Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in COVID-19 | Company's PlaCCine® technology platform demonstrates better durability and other advantages compared to mRNA vaccines Results further validate PlaCCine as a novel vaccine platform with potential applications... ► Artikel lesen | |
| BEYOND AIR | 0,170 | +3,03 % | Beyond Air: NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism | The FDA designation marks a significant milestone in the development of a novel treatment for a rare neurodevelopmental disorder Plan to initiate first-in-human U.S. clinical trials of lead drug candidate... ► Artikel lesen | |
| AVINGER | 0,340 | -6,08 % | Avinger Inc - 8-K, Current Report | ||
| NOVACYT | 0,469 | +0,11 % | Novacyt announces AGM scheduled for June 19, 2025 | ||
| AROVELLA THERAPEUTICS | 0,042 | 0,00 % | Biocurious: With its 'molecular Lego' approach, Arovella is building hope for cancer patients one brick at a time |
INSPIRA TECHNOLOGIES OXY BHN LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,028 (-5,19 %) liegt der Kurs bei 0,510 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INSPIRA TECHNOLOGIES OXY BHN LTD finden Sie auf Wallstreet Online.